A sleep and stress-reduction stack combining DSIP's direct sleep-promoting and sleep architecture-improving properties with Selank's daytime anxiolytic and mood-stabilising effects. DSIP is proposed to increase slow-wave delta sleep and normalise circadian sleep patterns by modulating hypothalamic sleep-wake centres, while Selank reduces anxiety, cortisol reactivity, and cognitive stress load that often prevents sleep onset. The combination targets both the quality of sleep and the psychological barriers to achieving it.
Mechanism
Proposed to increase slow-wave delta sleep duration and normalise disrupted sleep architecture by modulating hypothalamic sleep-wake regulatory centres — the primary sleep-inducing agent of the stack.
Reduces pre-sleep anxiety and cortisol reactivity through anxiolytic enkephalin modulation, addressing the psychological barrier to sleep onset that DSIP alone cannot target.
Dual-pathway activation
DSIP × Selank
DSIP (delta sleep-inducing peptide) is a research compound; the majority of human data originates from 1970s–1980s studies with limited modern independent replication. Selank is a Russian-developed synthetic peptide not FDA-approved in the United States. Potential interactions with existing sleep medications, benzodiazepines, or anxiolytics are not characterised and warrant caution when combining. No formal safety data exists for this combination.
Primary literature is 1980s with limited modern replication
Effect of Selank on Anxiety
Dihexa is researched as a potent hepatocyte growth factor (HGF/c-Met) modulator that promotes synaptogenesis and spatial memory. Semax, an ACTH analog, is investigated for BDNF upregulation and neuroprotective signaling in the brain. The combination is explored for its complementary routes to memory consolidation and cognitive resilience.
A complementary nootropic stack from Russian peptide research pairing Selank's anxiolytic and stress-modulating properties with Semax's BDNF-upregulating and cognitive-enhancing effects. Selank reduces anxiety and stabilises mood via modulation of the enkephalin system and GABAergic tone, while Semax enhances focus, memory consolidation, and neuroprotection through BDNF and ACTH-related pathways. Together they aim to eliminate cognitive friction while amplifying mental output.
MK-677 (ibutamoren), an orally active ghrelin mimetic, is commonly researched for improving REM and slow-wave sleep alongside GH pulse enhancement. Combined with Epithalon's research into pineal peptide bioregulation and telomere dynamics, this stack is explored for both sleep quality and longevity-related outcomes.
⚠ Educational Use OnlyPeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.
Free newsletter
The Peptide Research Digest
Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.